Skip to main content
Leiden University
Scholarly Publications
Home
Submit
About
Select Collection
All collections
Academic speeches
Dissertations
Faculty of Archaeology
Faculty of Governance and Global Affairs
Faculty of Humanities
Faculty of Science
Faculty of Social and Behavioural Sciences
Leiden Journals, Conference Proceedings and Books
Leiden Law School
Leiden University Press
Medicine / Leiden University Medical Centre (LUMC)
Research output UL
Search box
Your Search
Enabled Filters
(-)
= Yang, J.C.H.
Sort Options
Date (year)
Author / Creator
Title
Refine Results
Resource Type
Article / Letter to editor
(7)
+
-
Availability
Open access
(7)
+
-
Creation Date
2023
(3)
+
-
2022
(2)
+
-
Faculty
Leiden University Medical Center (LUMC)
(4)
+
-
Collection
Medicine / Leiden University Medical Centre (LUMC)
(4)
+
-
Scholarly Publications
(3)
+
-
Author
Smit, E.F.
(7)
+
-
Yang, J.C.H.
(7)
+
-
Felip, E.
(4)
+
-
Paik, P.K.
(4)
+
-
Bruns, R.
(3)
+
-
Cortot, A.B.
(3)
+
-
Garassino, M.C.
(3)
+
-
Johne, A.
(3)
+
-
Mazieres, J.
(3)
+
-
Raskin, J.
(3)
+
-
Sakai, H.
(3)
+
-
Veillon, R.
(3)
+
-
Viteri, S.
(3)
+
-
Ahn, M.J.
(2)
+
-
Berghoff, K.
(2)
+
-
Chen, Y.M.
(2)
+
-
Cho, B.C.
(2)
+
-
Griesinger, F.
(2)
+
-
Kim, D.W.
(2)
+
-
Kim, S.W.
(2)
+
-
Otto, G.
(2)
+
-
Patel, J.D.
(2)
+
-
Stroh, C.
(2)
+
-
Tan, D.S.W.
(2)
+
-
Thomas, M.
(2)
+
-
X.N. le
(2)
+
-
Show more
Language
en
(7)
+
-
Search results
(1 - 7 of 7)
show grid
show list
save search
Trastuzumab deruxtecan in patients with HER2-mutant metastatic non-small-cell lung cancer
Safety, tolerability, and antitumor activity of zipalertinib among patients with non-small-cell lung cancer harboring epidermal growth factor receptor exon 20 insertions
Tepotinib treatment in patients with MET exon 14-skipping non-small cell lung cancer
Nazartinib for treatment-naive EGFR-mutant non-small cell lung cancer
Tepotinib efficacy and safety in patients with MET exon 14 skipping NSCLC
Real-world insights into patients with advanced NSCLC and MET alterations
Tepotinib in non-small-cell lung cancer with MET exon 14 skipping mutations